Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36226828.
- Also identified by DOI 10.7554/eLife.82437 and PMC identifier 9635880.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The type VI secretion system (T6SS) secretes antibacterial effectors into target competitors. <i>Salmonella</i> spp. encode five phylogenetically distinct T6SSs. Here, we characterize the function of the SPI-22 T6SS of <i>Salmonella bongori</i> showing that it has antibacterial activity and identify a group of antibacterial T6SS effectors (TseV1-4) containing an N-terminal PAAR-like domain and a C-terminal VRR-Nuc domain encoded next to cognate immunity proteins with a DUF3396 domain (TsiV1-4). TseV2 and TseV3 are toxic when expressed in <i>Escherichia coli</i> and bacterial competition assays confirm that TseV2 and TseV3 are secreted by the SPI-22 T6SS. Phylogenetic analysis reveals that TseV1-4 are evolutionarily related to enzymes involved in DNA repair. TseV3 recognizes specific DNA structures and preferentially cleave splayed arms, generating DNA double-strand breaks and inducing the SOS response in target cells. The crystal structure of the TseV3:TsiV3 complex reveals that the immunity protein likely blocks the effector interaction with the DNA substrate. These results expand our knowledge on the function of <i>Salmonella</i> pathogenicity islands, the evolution of toxins used in biological conflicts, and the endogenous mechanisms regulating the activity of these toxins.
Medical subject headings
- Bacterial Proteins
- Type VI Secretion Systems